Sharechat Logo

MARKET CLOSE: NZ shares extend gain as A2 hits new record; Ryman, Metlifecare, Summerset drop

Tuesday 24th October 2017

Text too small?

New Zealand shares eked out another gain as the market digested the details of the governing deals made by the incoming Labour government, with A2 Milk hitting a fresh record while retirement village stocks fell.

The S&P/NZX50 Index edged up 0.55 points, or 0.007 percent, to 8,130.10. Within the index, 21 stocks rose, 21 fell and eight were unchanged. Turnover was $205 million.

Matt Goodson, MD at Salt Funds Management, said the market was focused on the new government and figuring out the relative winners and losers from the policies announced as part of the deals Labour has made with New Zealand First and the Green Party.

Retirement stocks are set to be one of the biggest losers and starting to decline before the September election as Labour's polling improved. Goodson said the stocks have been huge beneficiaries of rising house prices, and moves to lessen immigration and increase house building will change the backdrop for those companies.

Ryman Healthcare was the worst performer, down 3.7 percent to $8.85. Metlifecare dropped 2.6 percent to $5.73, and Summerset Group Holdings fell 2.2 percent to $4.85. Arvida Group slipped 0.9 percent to $1.17, while outside the benchmark index Oceania Healthcare dropped 3 percent to 98 cents.

A2 Milk, which has booked strong gains this year as its sales in China continue to improve, was the best performer, up 3.6 percent to $8.28. 

"Particularly in the Australian market, there is a small number of stocks that attract momentum-type money," Goodson said, adding that the stock has benefited from the weaker kiwi dollar against the Australian dollar, along with other exporters. A study from the University of Auckland's Liggens Institute, released over the weekend, showed A2 Milk can help with symptoms of lactose intolerance, although Goodson said the research was "more of a marketing angle until more information is available."

Freightways rose 2.6 percent to $7.62, Z Energy gained 2 percent to $7.14 and Property for Industry advanced 1.9 percent to $1.63.

The Labour/NZ First coalition deal included plans for a full review of retail power pricing has been promised, although no further details have yet emerged. Goodson said the market is still trying to figure out what form the review will take.

"It's hard to say at this point exactly what this means, the impacts on the listed gentailers remains to be seen and it hasn't had a noticeable impact today," he said. Genesis Energy, the biggest energy retailer in New Zealand, rose 0.8 percent to $2.43, while Mercury New Zealand gained 0.4 percent to $3.445. Meridian Energy dropped 2.4 percent to $2.82 and Contact Energy fell 1.8 percent to $5.55.

Fletcher Building shares are in a trading halt and were last at $7.96, having dropped 25 percent this year, ahead of tomorrow's annual meeting as a review of its Building + Interiors (B+I) business unit hangs over the company's 2018 earnings outlook.

"The company is taking the necessary time to carefully consider this matter. We expect the trading halt to cease on Wednesday 25 October 2017, with the announcement of earnings guidance for the 2018 financial year," it said in a release to the stock exchange. Fletcher also said it expects to announce a new CEO prior to market opening tomorrow.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar eases on technical factors, buoyed by higher dairy prices
RBNZ eyes Westpac Australia money laundering failures
Heritage buys Golden Healthcare; not mystery Metlife suitor
Alliance margins improve as swine fever boosts global meat prices
RBNZ eyes Westpac Australia money laundering failures
Precinct eyes new developments as Commercial Bay keeps to revised schedule
End to Tower's three year dividend drought in sight
Vital Healthcare's manager appoints new independent director
Argosy lifts first-half profit 15.2% on valuation gains
Metlifecare attracts 'credible' bidder after biggest trading day in 2 1/2 years

IRG See IRG research reports